Technical / White Paper

Supply Chain Solutions for the Growing Orphan Drug Market

Published

Format: PDF file | Document type: Technical / White Paper

Supply Chain Solutions for the Growing Orphan Drug Market

Marken recognizes the pharma industry’s increased focus on rare disease treatments and the complexity of safely transporting them to patients residing in multiple countries, each with its own unique customs and regulatory requirements. Marken’s Direct to Patient service utilizes its team of experts in customs and trade compliance along with its extensive network of depot facilities and strategically located distribution centers throughout the world to provide timely global packaging, transport and tracking of orphan drug materials within regulatory, temperature and time constraints.

Latest content from Marken: Global Life Science Supply Chain Solutions

How companies are realizing the potential of virtual and hybrid clinical trials

Content provided by Marken: Global Life Science Supply Chain Solutions

How companies are realizing the potential of virtual and hybrid clinical trials

Virtual and hybrid clinical trials have arrived. Having learnt from pilot projects, pharma companies are systematically incorporating patient-centric services into trials, resulting in a significant minority of today’s studies featuring virtual elements....

Related resources from Marken: Global Life Science Supply Chain Solutions

Show more

Supplier info centre